KS

Kripal Singh

Director Director DIN 01965886
DIN 01965886 First appointment Feb 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2006
Shareholding value •••• Premium profile

About Kripal Singh

Data last updated:

Kripal Singh was a Director at Francis Remedies (India) Private Limited (2006–2021) and Director at Francis Developers Private Limited (2011–2014). The companies operate in Pharma and Construction.

DIN 01965886
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 2006

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20062006₹12.19 Cr (FY 2024)Active
Francis Developers Private Limited U70102UR2011PTC033663
Director13 Sep 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Francis Remedies (India) Private Limited
Francis Developers Private Limited
Premium access

Shareholding and investment profile for Kripal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kripal Singh

Kripal Singh was first appointed on 28 Feb 2006 as Director at Francis Remedies (India) Private Limited. The most recent appointment on record is 13 Sep 2011 at Francis Developers Private Limited.

Kripal Singh held 2 earlier board appointments: Francis Remedies (India) Private Limited (Director, 28 Feb 2006 to 03 May 2021); Francis Developers Private Limited (Director, 13 Sep 2011 to 31 Jul 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available